Parkwalk Advisors
Venture capital firm based in London, UK
Latest Parkwalk Advisors investments
Parkwalk Advisors has invested in these startups.
Scripta Therapeutics
Scripta secures £9.1m seed to reprogramme transcription networks for Alzheimer’s. Read more
NoBACZ
Healthtech NoBACZ lands £4.8m led by The Yield Lab with Adjuvo. NoBACZ's liquid bandage combines antibiotic-free treatment and a protective contamination barrier to reduce antibiotic use in farm animals. Read more
Trismik
AI evaluation startup Trismik raises £2.2m led by Twinpath Ventures. Trismik's platform combines adaptive testing and detailed ability scores to provide precise, cost-effective model evaluation. Read more
Enhanced Genomics
Biotech firm Enhanced Genomics raises £13.9m led by BGF with Parkwalk. Enhanced Genomics's 3D multi-omics platform combines three-dimensional mapping and cell-type specificity to identify drug targets. Read more
Ceryx Medical
Ceryx Medical raises $15 million to advance cutting-edge cardiac therapies, promising to enhance recovery for heart failure patients. Read more
Diffblue
Oxford's Diffblue grabs a £1M Innovate UK grant, paving the way for AI-powered coding efficiency. Invest in the future of software. Read more
Cambridge GaN Devices
Cambridge GaN Devices secures $32M funding to drive energy-efficient innovations, set to impact electric vehicles and data centres. Read more
Entia
Healthtech company Entia secures £16m Series A financing round led by BGF and Parkwalk, with funds designated for the UK commercial rollout and US regulatory approval of their remote patient monitoring solution for cancer treatment, Liberty. Read more
Investments By Sector
Parkwalk Advisors has invested in these sectors
| Healthtech | 30.8% |
| SaaS | 23.1% |
| Hardware | 15.4% |
| AI | 15.4% |
| Biotech | 15.4% |
